RNA editing study shows potential for more effective precision cancer treatment
If there is one thing all cancers have in common, it is they have nothing in common. A multi-center study […]
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University […] Glioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is poor, with a […] Melbourne researchers have made the surprise discovery that the ‘odd one out’ in a family of proteins known to drive […] A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School […] Matching unique genetic information from cancer patients’ tumors with treatment options — an emerging area of precision medicine efforts — […] The canine transmissible venereal tumor is a contagious cancer that has spread by mating among dogs worldwide. One unique feature […] The canine transmissible venereal tumor is a contagious cancer that has spread by mating among dogs worldwide. One unique feature […] Angiogenesis, the formation of new blood vessels, is essential for tumor growth. A new study reported in The American Journal […] In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination […]Colon Cancer
Technology used to map Mars now measuring effect of treatment on tumors
The role of ‘extra’ DNA in cancer evolution and therapy resistance: Extrachromosomal DNA can change levels of oncogene amplification
Odd one out: Protein goes against the family to prevent cancer
Personalized tumor vaccine shows promise in pilot trial: Vaccine against patients’ own tumors triggers a broad response, and induced five-year remission in one patient with advanced ovarian cancer
Machine learning finds tumor gene variants and sensitivity to drugs in The Cancer Genome Atlas
How tumors caused by STD quickly regress in dogs
How tumors caused by STD quickly regress in dogs
Biomarker helps identify ‘window of opportunity’ for cancer chemotherapy timing: This biomarker may help clinicians combine anti-angiogenesis and anticancer drugs more effectively to boost results
New immunotherapy for lung cancer shows promise of success: Novel combination of drugs is a huge step forward in cancer treatment